慢性関節リウマチに対するLobenzarit disodium (CCA) の多施設臨床評価

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Unknown venue

• Publication date

  1989-03-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.2492/JSIR1981.9.151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of lobenzarit disodium (CCA) against the abnormal immunological parameters in rheumatoid arthritis

  1987cited by this paper
• 新抗リウマチ剤, lobenzarit disodium (CCA) ; ラットアジュバント関節炎阻害作用における胸腺由来リンパ球の役割

  1984cited by this paper
• The effect of CCA (Lobenzarit disodium) on the suppressor T cell function and the production of autoantibodies in New Zealand Black and New Zealand White F1 mice

  1983cited by this paper
• 慢性関節リウマチに対するLobenzarit disodium(CCA)の臨床的検討--多施設共同試験

  1983cited by this paper
• Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.

  1980cited by this paper
• Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.

  1977cited by this paper
• In vitro synthesis of immunoglobulin by rheumatoid synovial membrane.

  1968cited by this paper

• The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis

  2005cites this paper